| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | 0.26588311 |
| NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0478540623811426 | 0.03724618 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0478540623811426 | -0.059652861 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0478540623811426 | -0.20418581 |
| NSC 326061 | 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide | 0.0478540623811426 | -0.16217105 |
| NSC 330507 | Tanespimycin | 0.0478540623811426 | 0.097548024 |
| NSC 359415 | Null | 0.0478540623811426 | 0.083518944 |
| NSC 38530 | Null | 0.0478540623811426 | -0.037438013 |
| NSC 48526 | Null | 0.0478540623811426 | 0.083779107 |
| NSC 48890 | Null | 0.0478540623811426 | 0.43570349 |